Literature DB >> 17391285

Chronic neuropathic pain: mechanisms, drug targets and measurement.

Nanna B Finnerup1, Søren H Sindrup, Troels S Jensen.   

Abstract

Neuropathic pain is common in many diseases or injuries of the peripheral or central nervous system, and has a substantial impact on quality of life and mood. Lesions of the nervous system may lead to potentially irreversible changes and imbalance between excitatory and inhibitory systems. Preclinical research provides several promising targets for treatment such as sodium and calcium channels, glutamate receptors, monoamines and neurotrophic factors; however, treatment is often insufficient. A mechanism-based treatment approach is suggested to improve treatment. Valid and reliable tools to assess various symptoms and signs in neuropathic pain and knowledge of drug mechanisms are prerequisites for pursuing this approach. The present review summarizes mechanisms of neuropathic pain, targets of currently used drugs, and measures used in neuropathic pain trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391285     DOI: 10.1111/j.1472-8206.2007.00474.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  25 in total

1.  The fundamental unit of pain is the cell.

Authors:  David B Reichling; Paul G Green; Jon D Levine
Journal:  Pain       Date:  2013-12       Impact factor: 6.961

Review 2.  A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs.

Authors:  Charles E Argoff; Daniel I Silvershein
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

3.  Using the Phenogen website for 'in silico' analysis of morphine-induced analgesia: identifying candidate genes.

Authors:  Paula L Hoffman; Beth Bennett; Laura M Saba; Sanjiv V Bhave; Phyllis J Carosone-Link; Cheryl K Hornbaker; Katerina J Kechris; Robert W Williams; Boris Tabakoff
Journal:  Addict Biol       Date:  2010-11-04       Impact factor: 4.280

Review 4.  Cadherin-based transsynaptic networks in establishing and modifying neural connectivity.

Authors:  Lauren G Friedman; Deanna L Benson; George W Huntley
Journal:  Curr Top Dev Biol       Date:  2015-02-11       Impact factor: 4.897

5.  Association of pain and CNS structural changes after spinal cord injury.

Authors:  Catherine R Jutzeler; Eveline Huber; Martina F Callaghan; Roger Luechinger; Armin Curt; John L K Kramer; Patrick Freund
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

6.  Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.

Authors:  Axel Becker; Gerd Geisslinger; Radovan Murín; Gisela Grecksch; Volker Höllt; Andreas Zimmer; Helmut Schröder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-01       Impact factor: 3.000

Review 7.  Neuropathic pain: a maladaptive response of the nervous system to damage.

Authors:  Michael Costigan; Joachim Scholz; Clifford J Woolf
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

Review 8.  Cannabinoid-opioid interactions during neuropathic pain and analgesia.

Authors:  Ittai Bushlin; Raphael Rozenfeld; Lakshmi A Devi
Journal:  Curr Opin Pharmacol       Date:  2009-10-25       Impact factor: 5.547

9.  Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.

Authors:  Andreas Binder; Jean Bruxelle; Peter Rogers; Guy Hans; Irmgard Bösl; Ralf Baron
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

10.  Effect of sildenafil on neuropathic pain and hemodynamics in rats.

Authors:  Lan Ji Huang; Myung Ha Yoon; Jeong Il Choi; Woong Mo Kim; Hyung Gon Lee; Yeo Ok Kim
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.